The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1963, 90: 703-710.
Copyright © 1963 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, R. S.
Right arrow Articles by Dameshek, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, R. S.
Right arrow Articles by Dameshek, W.

The Role of Antigen Dosage in Drug-Induced Immunologic Tolerance1

Robert S. Schwartz and William Dameshek

From the Tufts University School of Medicine and the Blood Research Laboratory, Pratt Clinic-New England Center Hospital, Boston, Massachusetts

Abstract

The effect of varying the dosage of antigen (bovine serum albumin (BSA)) on the induction of immunologic tolerance in adult rabbits by the administration of a constant amount (10 mg/kg) of 6-mercaptopurine (6-MP) was studied. The doses of BSA employed ranged from 0.066 mg/kg to 66.0 mg/kg. Tolerance was not regularly achieved at doses of BSA below 66.0 mg/kg. The specificity of the tolerant state was demonstrated by normal responses to BGG, which was administered after the cessation of 6-MP treatment. It is proposed that the induction of immunologic tolerance by 6-MP is due to a state of relative antigen excess brought about by the administration of antigen to an animal whose lymphoid system has been depleted by the cytotoxic drug. The states defined as immunologic tolerance induced in young animals, immunologic paralysis and immunologic unresponsiveness may all depend on an increase in antigen relative to the number of available antibody-forming cells.

Footnotes

1 Aided by USPHS Grants E-3091 (C1) and H-5373, and Atomic Energy Commission Grant AT (30-1)2032.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.